| 000 | 01703nam a2200421Ia 4500 | ||
|---|---|---|---|
| 001 | EBC3018953 | ||
| 003 | MiAaPQ | ||
| 005 | 20240121041623.0 | ||
| 006 | m o d | | ||
| 007 | cr cn||||||||| | ||
| 008 | 090731s2010 nyua sb 001 0 eng d | ||
| 010 | _z 2009031817 | ||
| 020 | _z9781612093680 | ||
| 020 | _z9781607415657 (hardcover) | ||
| 020 | _z1607415658 (hardcover) | ||
| 035 | _a(MiAaPQ)EBC3018953 | ||
| 035 | _a(Au-PeEL)EBL3018953 | ||
| 035 | _a(CaPaEBR)ebr10662759 | ||
| 035 | _a(OCoLC)699510130 | ||
| 040 |
_aMiAaPQ _cMiAaPQ _dMiAaPQ |
||
| 050 | 4 |
_aRJ560 _b.S24 2010 |
|
| 082 | 0 | 4 |
_a615/.190083 _222 |
| 245 | 0 | 0 |
_aSafety efforts in pediatric drug development _h[electronic resource] / _cConor D. Byrne, editor. |
| 260 |
_aNew York : _bNova Science Publishers, _cc2010. |
||
| 300 |
_axiv, 133 p. : _bill. |
||
| 490 | 1 | _aPharmacology--research, safety testing and regulation series | |
| 504 | _aIncludes bibliographical references and index. | ||
| 533 | _aElectronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. | ||
| 610 | 1 | 0 |
_aUnited States. _tBest Pharmaceuticals for Children Act. |
| 650 | 0 |
_aPediatric pharmacology _zUnited States. |
|
| 650 | 0 |
_aPediatrics _zUnited States _xFormulae, receipts, prescriptions _xSafety measures. |
|
| 650 | 0 |
_aDrug development _zUnited States _xSafety measures. |
|
| 655 | 4 | _aElectronic books. | |
| 700 | 1 | _aByrne, Conor D. | |
| 710 | 2 | _aProQuest (Firm) | |
| 830 | 0 | _aPharmacology-research, safety testing, and regulation series. | |
| 856 | 4 | 0 |
_uhttps://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=3018953 _zClick to View |
| 999 |
_c152123 _d152124 |
||